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Effects of Megestrol Acetate,
A Progestin, on Female Rats
LENORE SOUTHAM

Abstract. Silastic (c:limethylpolysiloxane) capsules containing megestrol acetate ( 6- methyl-17 ex: -acetoxypregna-4, 6- diene-3, 20-dione)
were implanted subcutaneously in mature female rats. The effects of
megestrol on the ovary, on fertility, on body weight, on adrenal
weight, and on physical activity were observed.
Megestrol acetate did not inhibit ovulation or fertility, and did not
reduce ovarian weight; thus it did not have an anti-gonadotrophic
effect at the dosages used. It affected vaginal cytology in a typical
progestational fashion producing a constant diestrus or mixed cell
smear.
Body weight increased during treatment and remained fairly constant after treatment stopped. Adrenal weight decreased during
treatment and returned to normal after treatment stopped. These
two effects may contribute to a decreased physical activity observed
in some rats. Continuing obesity after treatment stopped may account for the failure of some rats to regain normal activity. Obesity
may also be a factor in the inhibition of mating behavior observed in
some of the animals.

Progesterone is a steroid hormone produced by the corpus luteum.
It normally functions to stimulate the uterine epithelium to secrete in

anticipation of implantation of a fertilized ovum and is responsible for
the constant diestrus vaginal cytology which is characteristic of pregnancy. It tends to inhibit ovulation by acting as an anti-gonadotrophin
and may inhibit ACTH release or action when administered exogenously (1).
Synthetic progestins exhibit some of the same properties as progesterone, but not necessarily all of them nor to the same degre~ Some
synthetic progestins, for example, may induce adrenal atrophy while
others have no apparent effect ( 1).
The following is a study of the effects of megestrol acetate ( 6-methyl17 ex: -acetoxypregna-4,6-diene-3,20-dione), a synthetic progestin, on
mature female rats. It was initiated to study the anti-fertility properties of the drug and the effects of long term hormone therapy by
means of slow release silasic ( dimethylpolysiloxane) capsules implanted
subcutaneously. These capsules release the hormone at a constant rate
a long as any hormone remains ( 2). They presumably, therefore, offer
a method of administration which is constant rather than periodic as
are most other methods.
METHODS

Silastic capsules (32 mm. long, 0.132" I.D., 0.183" O.D.) containing 5 mg. megestrol acetate suspended in 0.2 ml. sterile Upjohn suspending media 100 were implanted subcutaneously in the dorsal region
of mature female rats. These capsules release approximately 70 µ.g
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of hormone per 24 hours per capsule in vitro (Kind, unpublished
data). The rats were divided into three experimental and one control
group of 15 animals each. Group I animals received one capsule,
Group II animals received two capsules, and Group III animals received four capsules implanted at two separate sites. The control group,
Group IV, received one capsule per animal of suspending media only.
The capsules were removed from five animals in each group 10 weeks
after implantation. All surgery was performed using ether anesthesia.
Food and water were supplied ad libidum. Vaginal smears were taken
daily for two weeks during treatment and for three weeks after treatment stopped. Smearing was started about three weeks after implantation of the capsules to minimize the effect of stress on the animals.
Body weights were recorded at the start of treatment and periodically
throughout the experiment.
Males and females from each group were placed together in a ratio
of three to two for three to seven days on Day 42 and again on Day 66
after implantation. Daily smears for sperm were taken and females
showing sperm was autopsied after 10 days.
The general physical activity was observed and the four groups were
compared qualitatively during and after treatment.
The females were autopsied either after mating, during megestrol
treatment, or after cessation of treatment. Body, adrenal, and ovarian
weights, and the number of corpora lutea, were recorded in mated rats.
The capsules were recovered and checked visually for the presence of
the medication. It was visible in all cases and the availability of megestrol acetate was, therefore, assumed to be constant.
RESULTS AND DISCUSSION

Results are summarized in Tables 1 and 2 and in Figure 1.
Table 1
Cycling Pattern During and After Treatment

Type of Cycle
4-5 days ..................
Irregular ······ .... ·······
Not cycling ···············

I

After Treatment
III
IV
II
15

9

6

6

9

15

During Treatment
I

5

II

III

IV

2

4

5

2

1

1

Table 1: Megestrol acetate affected the cycling pattern in all experimental groups
in proportion to the dosage. The controls, Group IV, exhibited a normal 4- to 5day cycling pattern.

Ovulation occurred in all rats during treatment as indicated by the
presence of corpora lutea in the ovaries of all rats. Ovarian weights
were within the normal range. Normal fertility was indicated by comparable numbers of uterine implantation sites in the mated females from
each group. These indicate that the ovary was not materially affected
by megestrol treatment at the dosa~e~ 1Jsect.
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Table 2
Autopsy Data

Group
No.

Mean Body Weight
(gms.)

Mean Organ Weight
(mgs.)

Initial

Adrenals

I

Final

267

T
p
T
p
T
p
T
p

347
368
365
363
400
388
340
360

Uterine
Implantation
Sites

Ovaries

65.1
77.4
62.6
75.5
66.1
80.1
79.7
86.5

86.6
13.4
89.0
271
82.2
12.2
II
84.2
276
III
86.9
10.0
80.7
273
IV
104.9
12.5
(Control)
74.2
Table 2: T: Data on rats autopsied during treatment. P: Data on rats autopsied
after cessation of treatment. Standard error was calculated for all weights and for
the number of uterine implantation sites. All weights and the number of uterine
implantation sites were within one standard error except for the T final body
weights of Groups II and III, the P final body weight of Group III, and the T
adrenal weights of Groups I-III which were within two standard errors of the
control weights.
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Figure 1. The mean body weight gain is proportional to the dosage of megestrol

acetate.
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The vaginal cytology, which normally exhibits a four- to five-day
cyclical pattern, was affected in all treated groups and was normal in
the controls. The degree of effect was roughly proportional to the
dosage of the drug. No cyclical change was apparent in any of the
Group III animals or in a large proportion of the Group I and II
animals. Some of the Group I and II animals exhibited irregular cycling characterized by mixed-cell vaginal smears. The irregular cycling
is probably due to concurrent effects of endogenous and exogenous
hormones, while no apparent cycling is probably due to complete masking of the endogenous hormonal effects by the exogenous hormone.
Vaginal cytology is ordinarily a reliable index of the ovarian cycle
and the ovarian cycle is controlled by pituitary gonadotrophins. The
release of gonadotrophins is controlled largely by the response of the
hypothalamus to steroid hormone feedback from the ovaries. Exogenous hormones may influence the vaginal cytology directly or via a
pituitary-ovarian pathway. In the present study, the effect was apparently local since the ovaries did not appears to be influenced.
The vaginal cycling pattern returned to normal in most rats after
treatment was stopped. The failure of a few animals to return to the
normal cycling pattern may have been due to causes other than the
treatment. In any case, the number of animals involved is too small
to establish a positive correlation.
Megestrol treatment resulted in increased body weight in animals
in Groups II and III. The gain was proportional to the dosage. The
variation in amount of gain from animal to animal within a given
group, illustrated by a larger standard error in the calculated weight
of treated groups, may be due to location of the capsule in regions with
differing vascularity. A low vascular supply might reduce the rate of
absorption of exogenous hormone. Another factor might be the formation of fibroblast tissue around the capsules. This would reduce
the rate of diffusion of hormone from the capsule. The animals did not
lose weight after the capsules were removed, but neither did they continue to gain.
Adrenal weight decreased slightly during treatment indicating possible adrenal suppression. This effect was reversible. The adrenals
returned to normal weight after the progestin capsules were removed.
Megestrol acetate treatment resulted in a decrease in apparent
physical activity, especially in Group III. Most of the rats resumed
normal activity after cessation of treatment. The decreased adrenal
weight and decreased physical activity during treatment and the return
to normal adrenal weight and physical activity after treatment suggests
that the reduced activity may be due to decreased adrenal function.
Another possible factor is obesity. The reduced activity remaining in
some animals after treatment is probably a function of continuing
obesity.
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Inhibition of mating behavior in some animals may be related to
obesity since in all cases animals which failed to mate were heavier
than those which mated.
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